Singapore: Clearbridge Health debuts on SGX Catalist

Singapore-based healthcare firm Clearbridge Health Limited debuted on the Catalist, the growth board of the Singapore Exchange (SGX) on 18 December, Monday, at its issue price. Post-listing, the firm is valued at S$134.7 million ($99.8 million).

It briefly surged to a high of 29 cents per share before trading at 28 cents at market close. As at 19 December, it was trading at its issue price at 1100hrs.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter